If you are new to tirzepatide and haven't completed your initial titration period, consider scheduling flights after you've reached a stable dose for at least 23 weeks
For many patients, this mechanism leads to significant and sustained weight loss
Challenge 4: food aversions developing during treatment Many tirzepatide users develop unexpected food aversions
Diabetes, Obesity & Metabolism, 16 (10), 971976
It is widely available and inexpensive
The US Food and Drug Administration approved this first-in-class medication for the management of type 2 diabetes (T2D) in 2022 [2], for the reduction of excess weight in adults with obesity or overweight in 2023 [3], and for moderate-to-severe obstructive sleep apnea (OSA) in people with obesity in 2024 [4]